HPC
AMED

HM Payson & Co’s Amedisys AMED Stock Holding History

HM Payson & Co’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$1K – 1074
2021
Q3 		$1K Hold
8
– – ﹤0.01% 1028
2021
Q2 		$2K Hold
8
– – ﹤0.01% 978
2021
Q1 		$2K Hold
8
– – ﹤0.01% 1028
2020
Q4 		$2K Hold
8
– – ﹤0.01% 1003
2020
Q3 		$2K Buy
+8
New +$1.82K ﹤0.01% 940

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

HM Payson & Co's AMED Position: Q4 2021 in Review

HM Payson & Co sold out of Amedisys (AMED) in Q4 2021, closing a stake of 8 shares — an estimated $1K sold.

HM Payson & Co first reported a position in AMED in Q3 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • HM Payson & Co reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • HM Payson & Co sold 8 Amedisys shares in Q4 2021, an estimated $1K.
  • HM Payson & Co first reported a position in Amedisys in Q3 2020 and held it in 5 quarters.
  • HM Payson & Co's Amedisys position peaked at $2K in Q2 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.